Implants 1999;14:529–35. 48 Lee HR, Hong YJ, Chung S, et al. Proposal of standardized guidelines for the 66 Anitua E, Andía I, Sanchez M, et al. Autologous preparations rich in growth factors production and quality control of autologous serum eye drops in Korea: based on a promote proliferation and induce VEGF and HGF production by human tendon cells nationwide survey. Transfusion 2014;54:1864–70. 67 Hartwig D, Harloff S, Liu L, et al. Epitheliotrophic capacity of a growth factor nhsbt.nhs.uk/tissueservices/pdf/Autologous_Serum_Eyedrops_Service_leaflet%20_ preparation produced from platelet concentrates on corneal epithelial cells: 21_10_2008.pdf (accessed Mar 2015). a potential agent for the treatment of ocular surface defects? Transfusion 50 Liu L, Hartwig D, Harloff S, et al. An optimised protocol for the production of 2004;44:1724–31. autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol 2005;243:706–14. jgsbahikdnkaioyqiHBJAGIUGAIUGjjbdbfkjsjdfjdoiyhawnsmbbcjsgvhjfn egfdigesjdfjbdsjfhjsdf jgfsdbisjdgfbjshdfjbeusjd